Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study-Reference-Cited by-同舟云学术

Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study

Published:2023-05-09 Issue:3 Volume:10 Page:447-457
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Ouchi Dan^ORCID,Vilaplana-Carnerero Carles,Monfà Ramon,Giner-Soriano Maria,Garcia-Sangenís Ana,Torres Ferran,Morros Rosa

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-023-00374-2.pdf

Reference39 articles.

1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of type 2 diabetes: global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107.

2. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). Endocrinologist. 1999;9(6):503.

3. Vlacho B, Mata-Cases M, Mundet-Tudurí X, Vallès-Callol JA, Real J, Farre M, et al. Analysis of the adherence and safety of second oral glucose-lowering therapy in routine practice from the Mediterranean area: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12(Jul):1–8.

4. Lind M, Pivodic A, Cea-Soriano L, Nerman O, Pehrsson NG, Garcia-Rodriguez LA. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK. Diabetologia. 2014;57(8):1586–94.

5. Huang ES, Davis AM. Glycemic control in older adults with diabetes mellitus. JAMA. 2015;314:1509–10.